A team of Spanish researchers will study the potential of a chemotherapy drug combined with THC and CBD to shrink tumours and increase survival times in patients suffering an aggressive form of brain cancer called glioblastoma multiforme (GBM).
Tilray is a registered participant in the clinical trial.
THC, CBD and chemo drug
Patients will be treated with a combination of cannabinoids and the chemotherapy drug (TMZ) in the Spanish cities of Barcelona, Mallorca and Valencia.
It’s expected that preliminary results would be available approximately one year after the study begins.
Positive results published
A team of Spanish researchers last month published in Biochemical Pharmacology the results of an experimental study that found the combination of TMZ and oral cannabinoids (THC and CBD) produced “a strong antitumoral effect” in tumor cell samples and could be “therapeutically exploited for the management of GBM.”
GW Pharmaceuticals study
The results of a clinical trial completed by GW Pharmaceuticals in 2016 have\ not been published, but the company subsequently announced a 83% survival rate among 21 patients, compared with 53% in the placebo group.